2018
DOI: 10.1093/cid/ciy614
|View full text |Cite
|
Sign up to set email alerts
|

Direct Diagnostic Tests for Lyme Disease

Abstract: Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens and have a number of shortcomings. These serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable. New approaches have effectively been applied to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
70
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(70 citation statements)
references
References 41 publications
0
70
0
Order By: Relevance
“…Serological examination is widely used and is available in the clinical setting. Frequently used assays are enzyme-linked immunosorbent assay (ELISA), immunofluorescence assays, and Western blotting (Tugwell, 1997;Schutzer et al, 2018), but false-negative and false-positive results may occur (Schutzer et al, 2018). ELISA is recommended as the initial serological examination.…”
Section: Diagnosismentioning
confidence: 99%
“…Serological examination is widely used and is available in the clinical setting. Frequently used assays are enzyme-linked immunosorbent assay (ELISA), immunofluorescence assays, and Western blotting (Tugwell, 1997;Schutzer et al, 2018), but false-negative and false-positive results may occur (Schutzer et al, 2018). ELISA is recommended as the initial serological examination.…”
Section: Diagnosismentioning
confidence: 99%
“…Box 1 consolidates some of the major themes and recommendations explored in this review. Across the board, there is a recognized need for diagnostic tools that capture all stages of the disease, and can be used to monitor the infection status and evaluate microbiological eradication [347]. As high-quality direct-detection techniques evolve from interdisciplinary research, they will in turn accelerate clinical studies by affording investigators a higher resolution biological view of disease progression and treatment outcomes.…”
Section: Conclusion and Future Frontiersmentioning
confidence: 99%
“…Given the well-known limitations of immunoblot-based testing, MTTT provides a promising alternative testing strategy for children and adolescents with suspected Lyme disease. New host-or pathogen-based approaches for the diagnosis of Lyme disease are still needed to avoid both under-and overdiagnosis (19,22).…”
Section: Discussionmentioning
confidence: 99%